Form 4 for GILD Gilead Sciences
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-12 · accession 0001860008-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-13 | 2025-11-12 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | $65.35 | +53.6K | 79.6K | +206% | +$3.51M |
| DM | 2025-11-13 | 2025-11-12 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | S - Sale+OE | $122.85 | -53.6K | 43.7K | -55% | -$6.59M |
| DM | 2025-11-13 | 2025-11-12 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | $0.00 | -53.6K | 12.7K | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-12 | M | A | 17,181 | $75.12 | 60,857 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-12 | S | D | 17,181 | $124.00 | 43,676 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-12 | S | D | 500 | $122.90 | 43,676 | D | — | — | (F3) Sales prices for the transactions reported here range from $122.88 to $122.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 4 | Common | Common Stock | 2025-11-12 | S | D | 35,965 | $122.30 | 43,676 | D | — | — | (F2) Sales prices for the transactions reported here range from $121.87 to $122.83. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 5 | Common | Common Stock | 2025-11-12 | M | A | 500 | $60.75 | 44,176 | D | — | — | |
| 6 | Common | Common Stock | 2025-11-12 | M | A | 35,965 | $60.75 | 79,641 | D | — | — | |
| 7 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-11-12 | M | D | 17,181 | $0.00 | 37,799 | D | $75.12 · — to 2034-03-10 | 17,181 Common Stock | (F4) The stock options have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 8 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-11-12 | M | D | 500 | $0.00 | 12,155 | D | $60.75 · — to 2032-07-25 | 500 Common Stock | (F4) The stock options have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 9 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-11-12 | M | D | 35,965 | $0.00 | 12,655 | D | $60.75 · — to 2032-07-25 | 35,965 Common Stock | (F4) The stock options have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |